Loading clinical trials...
Loading clinical trials...
PICOLO is a double blind placebo controlled phase II dose ranging, dose escalating study in patients of Blalock-Taussig age categories (neonates and infants/toddlers), to determine the dose providing ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanofi
Collaborators
NCT06442592 · Congenital Heart Defects, Neurodevelopmental Disorder
NCT06961175 · Blood Platelet Disorders, Cardiac Surgery, and more
NCT01196182 · Congenital Heart Defects
NCT07040579 · Congenital Heart Defects, VSD
NCT00740870 · Congenital Heart Defects, Dysfunctional Right Ventricular Outflow Tract Conduits
Sanofi-Aventis Administrative Office
Bridgewater, New Jersey
Sanofi-Aventis Administrative Office
Diegem
Sanofi-Aventis Administrative Office
Laval
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions